Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 28,262,332	$ 7,908,181
Accounts receivable	515,450	216,504
Receivable from noncontrolling interests	0	721,548
Prepaid expenses and other current assets	3,248,432	1,664,023
Deferred offering costs	45,000	0
Total current assets	32,071,214	10,510,256
Property and equipment, net	17,774,788	10,712,839
Operating lease right-of-use assets, net	1,417,402	1,258,701
Goodwill	3,289,163	3,267,103
Other noncurrent assets	208,367	1,793,014
Total assets	54,760,934	27,541,913
Current liabilities:
Accounts payable	2,432,857	1,111,819
Accrued expenses	2,455,510	1,311,245
Notes payable	31,610	470,396
Finance lease liabilities - current	120,595	61,941
Operating lease liabilities - current	541,796	336,564
Deferred revenue	882,000	882,000
Other current liabilities	1,240,724	1,500,000
Share liability	306,000	0
Total current liabilities	8,011,092	5,673,965
Deferred tax liabilities	71,093	110,578
Convertible notes payable, at fair value	29,086,669	0
Finance lease liabilities - noncurrent	562,566	207,092
Operating lease liabilities - noncurrent	1,014,774	1,066,647
Other liabilities	1,653,000	1,653,000
Total liabilities	40,399,194	8,711,282
Stockholders' equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023	0	0
Common stock, $0.01 par value; 500,000,000 shares authorized, 52,132,833 and 48,923,276 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	521,329	489,233
Additional paid-in capital	50,911,752	40,567,003
Accumulated deficit	(39,720,310)	(23,839,300)
Accumulated other comprehensive loss	(701,291)	(920,982)
Total ASP Isotopes stockholders' equity	11,011,480	16,295,954
Noncontrolling interests	3,350,260	2,534,677
Total stockholders' equity	14,361,740	18,830,631
Total liabilities and stockholders' equity	$ 54,760,934	$ 27,541,913